Heidi Kay

About

Dr. Kay has been working in drug development since 1999, where she was the lead inventor for a new class of anticancer drug candidates targeting STAT3, in collaboration with researchers at the H. Lee Moffitt Cancer Center. Her experience and career in research laboratories began as a laboratory assistant in 1984. Dr. Kay moved on to establish Jericho Sciences, LLC in 2009 to develop research discoveries to help improve the lives of HIV-infected individuals. Dr. Kay earned a PhD in Physical Chemistry in 1999 at the University of South Florida. She holds 13 patents, continues pursuing new applications and has published in leading research journals.

Investment Focus

Location

Fairfax Station, US